Through clinical trials, our medical experts evaluate the safety and effectiveness of new therapies and diagnostic tools for brain tumors. Clinical trials can also help our doctors compare the effectiveness of different aspects of your child’s care, or determine the causes of brain tumors.

MSK has the most robust clinical research program in the tristate area for young people with brain tumors. We offer a wide range of clinical trials and are members of the Pediatric Brain Tumor Consortium, the Children’s Oncology Group, and the Neurofibromatosis Clinical Trials Consortium.

If your child is eligible to participate in a clinical trial, he or she may have access to new therapies that are not yet available elsewhere. Our clinical research team is highly experienced in selecting children who are most likely to benefit from a particular investigational therapy. They can guide you through the process of choosing the most appropriate clinical trial for your child’s needs.

Here you can find a list of many of Memorial Sloan Kettering’s current clinical trials for pediatric brain tumors. To learn more about a study, choose from the list below.